
    
      Focus of this trial is to assess the role a modified dose of PDR- and HDR-brachytherapy as
      Accelerated Partial Breast Irradiation (APBI) alone in a defined low-risk group of invasive
      breast cancer or ductal carcinoma in situ concerning local failure(all ipsilateral local
      recurrences, in particular regarding the local recurrences, the toxicity and for the cosmetic
      result.
    
  